Nitrous Oxide (Nangs): Public Health Information and Regulation in Australia

Nitrous Oxide (Nangs)

Nitrous oxide, commonly referred to as “nangs,” is a colourless, odourless gas with established uses in food preparation, medicine, and dentistry. In culinary settings, it is used in whipped cream dispensers. In medical contexts, it is used in controlled environments alongside oxygen for sedation and pain relief.

In recent years, nitrous oxide has received increased attention from health authorities and regulators in Australia due to reports of misuse and associated health impacts.

Nangs in Australia

Reported Health Effects Associated With Misuse

According to Australian health professionals and hospital reports, misuse of nitrous oxide through inhalation has been associated with a range of adverse health outcomes. These include neurological symptoms such as numbness, loss of coordination, difficulty walking, and, in some cases, psychiatric symptoms including psychosis.

Medical specialists have reported that prolonged or heavy misuse can lead to vitamin B12 depletion, which may impair nerve function and damage the spinal cord. Some patients have required hospital treatment, rehabilitation, and vitamin supplementation. Recovery outcomes vary and are not guaranteed.

Health authorities have noted that symptoms may develop over extended periods of repeated exposure, though individual cases can differ.

Access and Distribution

Nitrous oxide products are sold in Australia for legitimate purposes, including food preparation. They are available through retail outlets and online services, including delivery platforms.

Public reporting has highlighted that some nitrous oxide products can be ordered online and delivered rapidly. This accessibility has been referenced in discussions around public health and regulatory oversight.

Regulatory Status of Nitrous Oxide in Australia

Under Australian Consumer Law, the sale of nitrous oxide for legitimate purposes, such as food preparation and whipping cream, is lawful.

In 2022, the Therapeutic Goods Administration (TGA) reclassified nitrous oxide as a Schedule 6 (Poison) substance. This classification requires products sold in Australia to carry appropriate warning statements and safety directions in accordance with federal labelling requirements.

Regulation of the sale and supply of nitrous oxide varies by state and territory. Across Australia, state-based regulatory measures may include:

• Prohibitions on the sale or supply of nitrous oxide to minors

• Restrictions on certain retail sale practices, including time-based limitations

• Limits on container sizes or quantities in specific jurisdictions

• Offences relating to the sale or supply of nitrous oxide where there is knowledge or reasonable belief it will be inhaled

  
  

Western Australia, South Australia, Victoria, and other jurisdictions have introduced or amended legislation reflecting one or more of these approaches.

Regulatory Position in New South Wales (NSW)

In New South Wales, nitrous oxide remains lawful to sell and possess when supplied for legitimate purposes, including food preparation.

NSW legislation does not impose a blanket prohibition on the sale of nitrous oxide to adults. However, offences may arise under existing laws if nitrous oxide is sold or supplied in circumstances where there is knowledge or reasonable belief that it will be misused, including inhalation for intoxication.

Key regulatory considerations applicable in NSW include:

• It is an offence to sell or supply nitrous oxide to a person under the age of 18

• Supplying nitrous oxide with knowledge or reasonable belief it will be inhaled may constitute an offence

• Nitrous oxide products are subject to general consumer product safety and labelling requirements

  
  

Unlike some other Australian jurisdictions, New South Wales does not currently impose specific statutory limits on container size or uniform restrictions on hours of sale for nitrous oxide products. Oversight is applied through existing legislative frameworks rather than prescriptive retail controls.

Regulatory settings in NSW are subject to review

Medical Treatment and Support

Medical guidance indicates that treatment for nitrous oxide-related harm typically involves cessation of use and supplementation of vitamin B12. Health professionals report that outcomes vary between individuals, with some experiencing partial recovery and others ongoing impairment.

There is currently no specific medication approved to reverse nitrous oxide-related neurological damage beyond supportive care and vitamin supplementation.

People seeking assistance for substance-related concerns in Australia can access confidential support services, including the National Alcohol and Other Drug Hotline.

Information and Public Awareness

Health agencies and regulators continue to publish information regarding nitrous oxide, its lawful uses, potential health risks associated with misuse, and applicable regulations. Public awareness campaigns focus on education, harm reduction, and compliance with existing laws.